Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 364 | 481 | 327 | 7,812 | 0 |
| Cost of Goods | 318 | 430 | 287 | 295 | N/A |
| Gross Profit | 46 | 51 | 40 | 7,517 | N/A |
| Operating Expenses | 18,798 | 14,121 | 10,485 | 8,115 | 5,951 |
| Operating Income | -18,434 | -13,640 | -10,158 | -303 | -5,951 |
| Interest Expense | 0 | -258 | 0 | 0 | 0 |
| Other Income | 408 | 0 | 91 | 5 | -248 |
| Pre-tax Income | -18,026 | -13,382 | -10,067 | -298 | -6,199 |
| Net Income Continuous | -18,026 | -13,382 | -10,086 | -298 | -6,199 |
| Net Income | $-18,026 | $-13,382 | $-10,086 | $-298 | $-6,199 |
| EPS Basic Total Ops | -1.14 | -0.88 | 0.32 | -0.02 | -0.70 |
| EPS Basic Continuous Ops | -1.14 | -0.88 | 0.12 | -0.02 | -0.67 |
| EPS Diluted Total Ops | -1.14 | -0.88 | 0.32 | -0.02 | -0.70 |
| EPS Diluted Continuous Ops | -1.14 | -0.88 | 0.12 | -0.02 | -0.67 |
| EBITDA(a) | $-18,383 | $-13,400 | $-10,100 | $-286 | $-5,864 |